NEW YORK (GenomeWeb News) – Waters will collaborate with the University of Warwick in research focused on developing and supporting the growth and adaptation of novel mass spectrometry technologies, including Waters' Synapt High Definition MS system.
The collaborative research agreement involves the establishment of The Waters Centre for BioMedical Mass Spectrometry at the University of Warwick, which will serve as a center of excellence in mass spectrometry techniques.
The company said that the "agreement paves the way for research projects leading to meaningful impact for analysts using biomedical mass spectrometry, validated by peer-reviewed publications, presentations at international conferences and an outreach education program."
The center will serve as a resource through which scientists can adopt cutting edge LC/MS-based techniques in life science, it said.
"I believe that this partnership between a proven technology leader and a leading research focused University will provide a platform for the development of many exciting new projects," James Scrivens, of the Department of Biological Sciences at the University of Warwick, said in a statement.